Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
or

Immune Therapeutics Inc (IMUN)

Immune Therapeutics Inc (IMUN)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0930 -0.0070 (-7.00%) 10/18/23 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0930 unch (unch) -
Quote Overview for Wed, Oct 18th, 2023
Day Low
0.0930
Day High
0.0930
Open 0.0930
Previous Close 0.1000 0.1000
Volume 1,812 1,812
Avg Vol 13,135 13,135
Stochastic %K 13.59% 13.59%
Weighted Alpha -88.44 -88.44
5-Day Change -0.0070 (-7.00%) -0.0070 (-7.00%)
52-Week Range 0.0668 - 1.3000 0.0668 - 1.3000
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K 7,780
  • Shares Outstanding, K 83,658
  • Annual Sales, $ 0 K
  • Annual Income, $ -3,540 K
  • EBIT $ -1 M
  • EBITDA $ -1 M
  • 60-Month Beta 0.46
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.04
  • Most Recent Earnings $-0.04 on 11/14/22
  • Next Earnings Date 11/13/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0720 +29.17%
on 10/11/23
Period Open: 0.0710
0.1000 -7.00%
on 10/11/23
+0.0220 (+30.99%)
since 09/18/23
3-Month
0.0668 +39.22%
on 09/18/23
Period Open: 0.7998
0.9000 -89.67%
on 07/24/23
-0.7068 (-88.37%)
since 07/18/23
52-Week
0.0668 +39.22%
on 09/18/23
Period Open: 1.3600
1.3000 -92.85%
on 11/01/22
-1.2670 (-93.16%)
since 10/18/22

Most Recent Stories

More News
Immune Therapeutics Appoints Chief Financial Officer and Chief Operating Officer

ORLANDO, FL, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTC PINK:IMUN) (“Immune” or “IMUN”), a specialty pharmaceutical company...

OTC.VN : 0.270 (-1.82%)
IMUN : 0.0930 (-7.00%)
Immune Therapeutics, Inc. Appoints Dr. Stephen Wilson as Chief Executive Officer

ORLANDO, FL, July 22, 2022 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTC Pink: IMUN) (“Immune” or “IMUN”), a specialty pharmaceutical company...

OTC.VN : 0.270 (-1.82%)
IMUN : 0.0930 (-7.00%)
Statera Biopharma and Immune Therapeutics Inc. Announce Strategic Agreement for Rights to Low Dose Naltrexone

FORT COLLINS, Colo., April 27, 2022 (GLOBE NEWSWIRE) -- Statera Biopharma (Nasdaq: STAB) (the “Company”), a leading biopharmaceutical company creating...

STAB : 0.0001 (unch)
IMUN : 0.0930 (-7.00%)
Immune Therapeutics Announces Restructuring Plan

Orlando, Florida , June 04, 2021 (GLOBE NEWSWIRE) -- Immune Therapeutics Inc. (OTC-PINK: IMUN) (the "Company") announced today that the Company has received and signed a non-binding term sheet to enter...

IMUND : 5.2500 (-8.54%)
IMUN : 0.0930 (-7.00%)
Immune Therapeutics Announces Financing and Debt Restructuring Plan

Orlando, Florida, June 02, 2021 (GLOBE NEWSWIRE) -- Immune Therapeutics Inc. (OTC-PINK: IMUND) (the "Company") announced today that the Company has received and signed a non-binding term sheet to enter...

IMUN : 0.0930 (-7.00%)
IMUND : 5.2500 (-8.54%)
Immune Therapeutics FINRA Approval for 1:1000 Reverse Stock Split

Orlando, Florida , May 11, 2021 (GLOBE NEWSWIRE) -- Immune Therapeutics Inc. (OTC-PINK: IMUN) (the "Company") announced today that FINRA has processed a reverse split of 1-for 1,000 of the issued and...

IMUN : 0.0930 (-7.00%)

Business Summary

Forte Biotechnology Intl Corp is a biotechnology company. Its goal is to acquire late stage modulator drugs and immune modulator biopharmaceuticals for cancer, chronic inflammation, pain and neurodegenerative disease in companion pets. Forte Biotechnology Intl Corp, formerly known as Immune Therapeutics...

See More

Key Turning Points

3rd Resistance Point 0.0930
2nd Resistance Point 0.0930
1st Resistance Point 0.0930
Last Price 0.0930
1st Support Level 0.0930
2nd Support Level 0.0930
3rd Support Level 0.0930

See More

52-Week High 1.3000
Fibonacci 61.8% 0.8289
Fibonacci 50% 0.6834
Fibonacci 38.2% 0.5379
Last Price 0.0930
52-Week Low 0.0668

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro